NCT02242981View on ClinicalTrials.gov

A Study of How the Body Breaks Down and Eliminates LY2623091

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

LY2623091

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02242981 - A Study of How the Body Breaks Down and Eliminates LY2623091 | Biotech Hunter | Biotech Hunter